DK616989A - Humane monoklonale antistoffer, der specifikt genkender rabiesvirusceller, celler, der prducerer denne virus, formuleringer, der indeholder virusen, samt fremstilling af disse antistoffer
- Google Patents
Humane monoklonale antistoffer, der specifikt genkender rabiesvirusceller, celler, der prducerer denne virus, formuleringer, der indeholder virusen, samt fremstilling af disse antistoffer
Download PDF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808153Aexternal-prioritypatent/GB8808153D0/en
Priority claimed from GB888823081Aexternal-prioritypatent/GB8823081D0/en
Priority claimed from PCT/EP1989/000365external-prioritypatent/WO1989009789A1/en
Application filed by Erba Carlo SpafiledCriticalErba Carlo Spa
Publication of DK616989D0publicationCriticalpatent/DK616989D0/da
Publication of DK616989ApublicationCriticalpatent/DK616989A/da
DK616989A1988-04-071989-12-07Humane monoklonale antistoffer, der specifikt genkender rabiesvirusceller, celler, der prducerer denne virus, formuleringer, der indeholder virusen, samt fremstilling af disse antistoffer
DK616989A
(da)
Humane monoklonale antistoffer, der specifikt genkender rabiesvirusceller, celler, der prducerer denne virus, formuleringer, der indeholder virusen, samt fremstilling af disse antistoffer
Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin
Humane monoklonale antistoffer, der specifikt genkender rabiesvirusceller, celler, der prducerer denne virus, formuleringer, der indeholder virusen, samt fremstilling af disse antistoffer
Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
Monoklonale antistoffer, der genkender specifikke glycoproteiner producerede af humant planocellulaert lungecarcinom celler, fremgangsmaade til fremstilling af saadanne antistoffer, samt deres diagnostiske anvendelse